
The US Public Paid to Develop This COVID-19 Drug. It Will Cost $3,000 a Dose.
The American public helped pay for the development of remdesivir, a COVID-19 drug. That same American public will now be charged $3,000 for a treatment — a treatment that experts say costs less than $10 to produce.